3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
1
Graft vs Host Disease
1
Interventions
Cyclophosphamide
6
fludarabine
5
Exercise
4
Blood Specimen Collection
4
Surveys and Questionnaires
3
Immunotherapy, Adoptive
3
thymoglobulin
2
pegylated granulocyte colony-stimulating factor
2
Voriconazole
2
Stem Cell Transplantation
2
Saline Solution
2
Physical Therapy Modalities
2
Parenteral Nutrition
2
Mycophenolic Acid
2
Etoposide
2
Cytarabine
2
CF regimen
2
BNT162 Vaccine
2
Azacitidine
2
venetoclax
1
trihexyltetradecylphosphonium chloride
1
treosulfan
1
shengxuening
1
ruxolitinib
1
ramosetron
1
monalizumab
1
glucarpidase
1
fludarabine phosphate
1
ferrous succinate
1
eltrombopag
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hematologic Neoplasms
×
trihexyltetradecylphosphonium chloride
×
Clear all
NCT05158608
2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3
Unknown
100 enrolled